Y-Intercept (HK)’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,421
Closed -$658K 1580
2024
Q3
$658K Buy
+4,421
New +$634K 0.04% 639
2022
Q4
Sell
-4,049
Closed -$758K 1292
2022
Q3
$758K Buy
+4,049
New +$854K 0.08% 386
2022
Q1
Sell
-1,309
Closed -$347K 912
2021
Q4
$347K Sell
1,309
-1,729
-57% -$466K 0.08% 351
2021
Q3
$878K Buy
+3,038
New +$779K 0.16% 205

Other funds holding RGEN

Y-Intercept (HK)'s RGEN Position: Q4 2024 in Review

Y-Intercept (HK) sold out of Repligen (RGEN) in Q4 2024, closing a stake of 4,421 shares — an estimated $658K sold.

Y-Intercept (HK) first reported a position in RGEN in Q3 2021 and held it in 4 quarters. The position peaked at $878K in Q3 2021. 431 funds tracked by Wall St. Rank hold RGEN as of Q4 2024.

  • Y-Intercept (HK) reported no remaining Repligen position as of Q4 2024 after selling out during the quarter.
  • Y-Intercept (HK) sold 4,421 Repligen shares in Q4 2024, an estimated $658K.
  • Y-Intercept (HK) first reported a position in Repligen in Q3 2021 and held it in 4 quarters.
  • Y-Intercept (HK)'s Repligen position peaked at $878K in Q3 2021.
  • 431 funds tracked by Wall St. Rank held Repligen as of Q4 2024.

Based on Y-Intercept (HK)'s 13F filing for Q4 2024, filed 4 Feb 2025.